# Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Study · id `cardio:ct-nct06744361` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06744361](<https://clinicaltrials.gov/study/NCT06744361>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06744361

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 282 participants.

## Technical summary

Registry record NCT06744361. Randomized; quadruple masking; primary purpose treatment. Start 2024-12-12 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 282 participants (planned count; ClinicalTrials.gov record NCT06744361, source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)
- Started: 2024-12-12 (actual) (ClinicalTrials.gov record NCT06744361, source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)
- Primary completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT06744361, source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)
- Completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT06744361, source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT06744361, source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06744361-2024-12-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
- Acronym: KETOHCA
- Condition: Out-of-hospital Cardiac Arrest (OHCA)
- Intervention (Drug): esketamine hydrochloride
- Intervention (Drug): propofol
- Lead sponsor: Christian Hassager
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Christian Hassager (`cardio:org-christian-hassager`)

## Provenance

Content hash: 0a6fc26334715c5bb0132e7ba31a466a97c237d84c19232c81ea9a3fc196aaff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
